Literature DB >> 231208

Evidence for cyclic GMP-mediated relaxant effects of nitro-compounds in coronary smooth muscle.

W R Kukovetz, S Holzmann, A Wurm, G Pöch.   

Abstract

The effects of the four nitro-compounds nitroglycerin, nitroprusside-Na, NaNO2 and B 744-99 were studied simultaneously on length and on cGMP-levels in isolated circular strips of bovine coronary arteries. 1. All 4 nitro-compounds concentration dependently relaxed the strips in close association with pronounced increases in cGMP-levels which preceded the mechanical responses. 2. The relaxant effects of all 4 nitro-compounds were significantly potentiated by the predominant inhibitor of cGMP-hydrolysis M & B 22,948, which also potentiated the increase in cGMP-levels of the two nitro-compounds in which it was studied (nitroglycerin and nitroprusside-Na). 3. Non-substituted cGMP and -- much stronger -- its 8 bromo-derivative also relaxed the strips and these effects were likewise potentiated by M & B 22,948. 4. When the log increase in cGMP produced by the 4 nitro-compounds were plotted against percent relaxation (probit scale) a linear and highly significant positive correlation was obtained. 5. The results provide evidence that the increases in cGMP caused by the 4 nitro-compounds studied are responsible for the smooth muscle relaxing actions of these drugs.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 231208     DOI: 10.1007/bf00500277

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  24 in total

1.  Relaxation of hormonally stimulated smooth muscular tissues by the 8-bromo derivative of cyclic GMP.

Authors:  K D Schultz; E Böhme; V A Kreye; G Schultz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-01       Impact factor: 3.000

2.  Cyclic nucleotides and the contraction of smooth muscle.

Authors:  R Andersson; K Nilsson; J Wikberg; S Johansson; E Mohme-Lundholm; L Lundholm
Journal:  Adv Cyclic Nucleotide Res       Date:  1975

3.  Increases in cyclic GMP levels may not mediate relaxant effects of sodium nitroprusside, verapamil and hydralazine in rat vas deferens.

Authors:  J Diamond; R A Janis
Journal:  Nature       Date:  1978-02-02       Impact factor: 49.962

4.  The effect of sodium nitroprusside on the uptake and efflux of 45Ca from rabbit and rat vessels.

Authors:  T T Zsotér; N F Henein; C Wolchinsky
Journal:  Eur J Pharmacol       Date:  1977-09-01       Impact factor: 4.432

5.  Cyclophosphates VI. Cyclophosphates as substrates and effectors of phosphodiesterase.

Authors:  G Michal; K Mühlegger; M Nelboeck; C Thiessen; G Weimann
Journal:  Pharmacol Res Commun       Date:  1974-06

6.  Stimulation of adenosine 3',5'-monophosphate hydrolysis by guanosine 3',5'-monophosphate.

Authors:  J A Beavo; J G Hardman; E W Sutherland
Journal:  J Biol Chem       Date:  1971-06-25       Impact factor: 5.157

7.  Studies on the possible role of cyclic AMP in drug-induced coronary vasodilatation.

Authors:  G Pöch; W R Kukovetz
Journal:  Adv Cyclic Nucleotide Res       Date:  1972

8.  The uptake of l- and d-norepinephrine by the isolated perfused rabbit heart in relation to the stereospecificity of the sensitizing action of cocaine.

Authors:  P R Draskóczy; U Trendelenburg
Journal:  J Pharmacol Exp Ther       Date:  1968-01       Impact factor: 4.030

9.  Quantitative estimation of overadditive and underadditive drug effects by means of theoretical, additive dose-response curves.

Authors:  G Pöch; S Holzmann
Journal:  J Pharmacol Methods       Date:  1980-09

10.  Effects of potassium chloride and smooth muscle relaxants on tension and cyclic nucleotide levels in rat myometrium.

Authors:  J Diamond; T G Holmes
Journal:  Can J Physiol Pharmacol       Date:  1975-12       Impact factor: 2.273

View more
  65 in total

1.  Contribution of cyclic GMP formation to KRN2391-induced relaxation in coronary artery of the pig.

Authors:  Y Jinno; H Kasai; H Ohta; K Nishikori; H Fukushima; N Ogawa
Journal:  Br J Pharmacol       Date:  1992-08       Impact factor: 8.739

2.  Effect of carbenoxolone on the biological activity of nitric oxide: relation to gastroprotection.

Authors:  A Dembinska-Kiec; D Pallapies; T Simmet; B M Peskar; B A Peskar
Journal:  Br J Pharmacol       Date:  1991-12       Impact factor: 8.739

3.  Proceedings of the British Pharmacological Society. 6th-8th January, 1988. Abstracts.

Authors: 
Journal:  Br J Pharmacol       Date:  1988-03       Impact factor: 8.739

Review 4.  Mechanisms of action of nitrates.

Authors:  K E Torfgård; J Ahlner
Journal:  Cardiovasc Drugs Ther       Date:  1994-10       Impact factor: 3.727

5.  The effect of M&B 22948 on methacholine- and histamine-induced contraction and inositol 1,4,5-trisphosphate levels in guinea-pig tracheal tissue.

Authors:  J M Langlands; I W Rodger; J Diamond
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

6.  On the haemodynamic differences between sodium nitroprusside, nitroglycerin, and isosorbide nitrates. Comparison of their vasorelaxant effects in vitro and of their inactivation in vivo.

Authors:  A Stiefel; V A Kreye
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-03       Impact factor: 3.000

Review 7.  Intravenous glyceryl trinitrate (nitroglycerin). A review of its pharmacological properties and therapeutic efficacy.

Authors:  E M Sorkin; R N Brogden; J A Romankiewicz
Journal:  Drugs       Date:  1984-01       Impact factor: 9.546

8.  Nitroglycerin relaxes canine coronary arterial smooth muscle without reducing intracellular Ca2+ concentrations measured with fura-2.

Authors:  T Yanagisawa; M Kawada; N Taira
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

9.  Bronchodilator-mediated relaxation of normal and ovalbumin-sensitized guinea-pig airways: lack of correlation with lung adenylate cyclase activation.

Authors:  J F Burka; M H Saad
Journal:  Br J Pharmacol       Date:  1984-11       Impact factor: 8.739

10.  Activation of purified soluble guanylate cyclase by protoporphyrin IX.

Authors:  L J Ignarro; K S Wood; M S Wolin
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.